Editor's Note
The Food & Drug Administration on June 4 announced that it had approved new labeling on potential risks for liquid-filled intragastric balloons by Apollo Endosurgery and ReShape Lifesciences.
The new labeling for the Orbera and ReShape balloon systems includes more information about possible deaths linked to the use of these devices.
Free Daily News